This application seeks renewal of T32 funding for the Tumor Biology Training Program (TBTP). TBTP is the premier graduate and postdoctoral training program at Georgetown University Medical Center (GUMC). TBTP is also the only NCI-funded training grant at Georgetown University (GU) and is the only GU training program dedicated to cancer research. In its 22 year history, the TBTP program has trained hundreds of young scientists, including many URM scientists, who have gone onto successful cancer?related careers in academia, industry and education. The mission of the TBTP is to provide trainees with a strong foundation in translational cancer research that will be required to eradicate human cancer. The program allows trainees to develop lifelong multidisciplinary skills that will enable them to make significant contributions in the eradication of human cancer and to fill a training need i.e. to interact productively in their future careers as collaborators with clinical research and population science programs. The scientist and physician mentors of TBTP are all drawn from the four integrated Lombardi NCI-designated Comprehensive Cancer Center (LCCC) programs. The mentors and trainees are focused on 1) understanding basic biological processes that drive initiation and progression of human cancer, 2) identifying critical targets for the development of novel therapeutics and therapeutic combinations and to enable monitoring of therapeutic response and development of resistance in patients, and 3) integrating the knowledge gained from research to the understanding of the prevention and control of human cancer. LCCC provides the foundation for the TBTP program, stimulating interdisciplinary collaborations and co-mentoring opportunities, as well as providing translational opportunities through an expanding clinical research initiative. In this application for renewal, we show how our program will evolve to meet the changing focus of translational cancer research by exposing trainees to a breadth of basic, clinical and population science research. Going forward we will challenge ourselves to 1) add additional new and invigorated training and career development opportunities for our trainees and 2) incorporate translational themes, with physician input, in all aspects of training consistent with the NCI mission of ?supporting cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.?

Public Health Relevance

The Tumor Biology Training Program (TBTP) is housed in Lombardi Comprehensive Cancer Center of Georgetown University in Washington D.C. D.C. has a predominantly underserved African American population and between 2008 and 2016, ranked 6th highest in the nation for cancer deaths, third for deaths due to colorectal cancer, and first for deaths due to prostate, cervical, and breast cancers. Our TBTP is designed to prepare the next generation of dynamic, diverse cancer researchers with lifelong learning skills so that they can make significant inroads into the understanding, prevention and treatment of cancer and to advance scientific knowledge so that all of our cancer patients can live longer and happier lives.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009686-24
Application #
10020917
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
1996-07-01
Project End
2024-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
24
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lelo, Alana; Prip, Frederik; Harris, Brent T et al. (2018) STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer. Clin Cancer Res 24:4145-4153
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Vera, Nicholas B; Chen, Zhidan; Pannkuk, Evan et al. (2018) Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation. J Mass Spectrom 53:548-559
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Tassi, Elena; Lai, En Yin; Li, Lingli et al. (2018) Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein). Hypertension 71:160-167
Speidell, Andrew P; Demby, Tamar; Lee, Yichien et al. (2018) Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotox Res :
Pannkuk, Evan L; Laiakis, Evagelia C; Fornace Jr, Albert J et al. (2018) A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation. Health Phys 115:3-11
Nomura, Sarah J O; Dash, Chiranjeev; Sheppard, Vanessa B et al. (2017) Sedentary time and postmenopausal breast cancer incidence. Cancer Causes Control 28:1405-1416
Hilakivi-Clarke, Leena; Wärri, Anni; Bouker, Kerrie B et al. (2017) Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model. J Natl Cancer Inst 109:

Showing the most recent 10 out of 214 publications